Coherus Oncology (CHRS) Intangibles (2016 - 2025)
Historic Intangibles for Coherus Oncology (CHRS) over the last 12 years, with Q3 2025 value amounting to $28.9 million.
- Coherus Oncology's Intangibles changed 0.0% to $28.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.9 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $28.9 million for FY2024, which is 3107.64% down from last year.
- Per Coherus Oncology's latest filing, its Intangibles stood at $28.9 million for Q3 2025, which was down 0.0% from $28.9 million recorded in Q2 2025.
- Coherus Oncology's Intangibles' 5-year high stood at $41.9 million during Q4 2023, with a 5-year trough of $2.6 million in Q1 2021.
- Moreover, its 5-year median value for Intangibles was $28.9 million (2023), whereas its average is $20.7 million.
- As far as peak fluctuations go, Coherus Oncology's Intangibles soared by 60596.86% in 2023, and later crashed by 3107.64% in 2024.
- Quarter analysis of 5 years shows Coherus Oncology's Intangibles stood at $3.6 million in 2021, then skyrocketed by 66.46% to $5.9 million in 2022, then surged by 605.97% to $41.9 million in 2023, then crashed by 31.08% to $28.9 million in 2024, then changed by 0.0% to $28.9 million in 2025.
- Its Intangibles was $28.9 million in Q3 2025, compared to $28.9 million in Q2 2025 and $28.9 million in Q1 2025.